Resultados: 4

    COVID-19 treatment guidelines panel: Coronavirus diseases 2019 (COVID-19) treatment guidelines

    The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other authorita...

    Substance use: family-based interventions to prevent substance use among youth

    Youth substance use is associated with increased risk for delinquency, academic underachievement, teen pregnancy, sexually transmitted infections, perpetrating or experiencing violence, injuries, and mental health problems (U.S. Department of Health and Human Services 2016). Preventing or delaying substa...

    The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

    The American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) developed this Clinical Practice Guideline on the Management of Stimulant Use Disorder (hereafter referred to as the Guideline) to provide evidence-based strategies and standards of care for the trea...

    Pan-American Guidelines for the Treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API) [Pré-print]

    Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been investigated at different stages of clinical manifestations. Considering the particular impact of COVID-19 in the Americas, this document aims to present recommendations for the pharmacological treatment of ...